Therapeutic Monoclonal Antibodies, 2006-2011 - Maximising the Growth Potential of a Stocked Pipeline

Released on = April 30, 2007, 9:36 pm

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = While the pharmaceutical as a whole is suffering from single
digit growth, thin uninspiring pipelines and pressure from an ever-aggressive
generics industry - not so for monoclonal antibody therapies.

Press Release Body = The market for monoclonal antibody treatments is one of the
most exciting segments of the pharmaceutical industry today. Are you and your
organisation benefiting from this growth?

The monoclonal market is set to expand dramatically. Ten years ago there were only
two monoclonal antibody drugs on the world market, now there are nineteen FDA
approved therapies - including six blockbuster drugs. The market in 2005 was worth
over $13bn, worldwide, representing an astounding growth of 37% - can you believe
it? Well you should and to make sure you capture an increased share of this growth
order this report NOW. Biotech pipelines are overflowing with over 160 monoclonal
antibody based drugs; the market is thriving!

Will the current monoclonal blockbusters continue to grow? What are the hottest
projects in the pipeline? What will restrain the market in the future? These are
questions you need to know the answers to.

Buy this new report to find out!

Included in this report :


This exhaustive and informative report includes over 100 pages of in-depth,
up-to-date, analysis and over 70 tables and figures, detailing the current market
and possible future developments. The following important issues are covered in
detail:

Visiongain\'s forecast for the world monoclonal antibody market, 2006-2011
Drivers and restraints of the fast growing world monoclonal antibody market are
identified and discussed
An analysis of strengths, weaknesses opportunities and threats (SWOT) for the
monoclonal antibody market
Summaries and revenue forecasts for the leading monoclonal antibody drugs, 2006-2011
A thorough examination of the monoclonal antibody pipeline
An assessment of future developments, including new antibody formats and conjugated
antibodies
You cannot afford to ignore this expanding market. A small investment today will be
the catalyst of a great return for your company tomorrow.

Unique benefits to you when you order this report :


- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using hard drive
space
- Primary research throughout. You will not find this information anywhere else
- Report stored in your reading room for ever
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables

If you buy one report this year make sure it is the report that will guarantee your
success for the next few years. Order this report now.

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium, Navi Mumbai - 400 614, India.
Ph. : +91-(022)-2757 8668 or +91-(022)-2757 9131
email : bharatbook@gmail.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •